Literature DB >> 22019953

Procalcitonin and C-reactive protein levels as diagnostic tools in febrile patients admitted to a General Internal Medicine ward.

Raul Ruiz-Esteban1, Pilar Relea Sarabia, Emilio García Delgado, Carlos Barros Aguado, Jose Amerigo Cuervo-Arango, Manuel Varela.   

Abstract

OBJECTIVE: We study the extent to which procalcitonin (Pro-CT) and/or C-reactive protein (CRP) may be helpful in the early triage of febrile patients admitted to a general internal medicine ward.
METHODS: This is a prospective, observational study on 62 admitted patients in whom a temperature >38°C had been observed the day before inclusion.
RESULTS: Neither Pro-CT nor CRP was able to discriminate infectious (or bacterial) diseases from the other etiologies as a group, with an area under the ROC curve of 0.63 (95% CI 0.47-0.79, p=0.15) for Pro-CT and 0.61, (95CI 0.44-0.78, p=0.23) for CRP. Sensitivity and specificity for Pro-CT varied between 0.59 and 0.67 for a cut-off point of 0.2 ng/mL and 0.03 and 1 for a cut-off point of 10.0 ng/mL. However, in subgroup analysis, Pro-CT was able to discriminate between infectious and inflammatory diseases (Welch two sample t-test t=2.39, df=44.3, p=0.021).
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019953     DOI: 10.1016/j.clinbiochem.2011.09.024

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Biomarkers in Shock Patients and Their Value as A Prognostic Tool; A Prospective Multi-Center Cohort Study.

Authors:  Ana Maria Navio Serano; Joaquín Valle Alonso; Gustavo Rene Piñero; Alejandro Rodriguez Camacho; Josefa Soriano Benet; Manuel Vaquero
Journal:  Bull Emerg Trauma       Date:  2019-07

Review 2.  The importance of serum procalcitonin in diagnosis and treatment of serious bacterial infections and sepsis.

Authors:  Snjezana Mehanic; Rusmir Baljic
Journal:  Mater Sociomed       Date:  2013-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.